Open original FDA record ↗Recall record
- FDA identifier
- Z-0269-06
- Company in FDA record
- Abbott Laboratories
- FDA classification date
- Dec 6, 2005
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 20, 2026
- Recall classification
- Unknown — no matched enforcement classification
Reason stated in the source
The product failed 12-month stability testing that can lead to falsely reduced hemoglobin (Hgb) test results.
Source facts
- Action
- On September 20, 2005, the firm issued letters to all its direct consignees, informing them of the affected product and providing instructions on the recall. In February, the firm expanded its recall to all lots as a result of having identified an additional failure in a different lot.
- Initiated
- 2005-09-20
- Root cause
- Other
- Terminated
- 2006-11-02
- Distribution
- Distribution of DILUENT is worldwide to a total of 1,584 consignees. All CELL-DYN 1800 customers were notified via the Device Recall Letter. At the time of receipt of the letter, the customer may or may not have the recalled lots in their inventory. Therefore, the letter directed the customer to assess their inventory of DILUENT 08H17-01 and 99226-01 to determine if they had any of the affected lots in their possession. Foreign countries include: Canada, Columbia, Uruguay, Germany, Barbados, Bermuda, Cayman Islands.
- Recall number
- Z-0269-06
- Recall status
- Terminated
- CDRH record ID
- 42161
- FDA classified
- 2005-12-06
- Recall event number
- 33616